Deficiency in 3’UTR may contribute to the onset of various cancers which in turn accelerate the development of target therapy, for instance, the shortening of the KHDRBS1 mRNA 3’UTR can mediate the upregulation of KHDRBS1 and promote the progression of gastric cancer (21). Here, KHDRBS1 is linked to cancer.